摘要
目的观察信必可都保治疗支气管哮喘的临床疗效。方法选择我院50例哮喘患者,吸入信必可都保治疗,观察患者的症状、最大呼气峰流速值(PEF)、哮喘控制水平分级的变化及不良反应情况。结果经过3个月的治疗,患者的临床症状、肺功能均有明显改善。结论吸入信必可都保可有效控制中-重度哮喘发作,改善肺功能和生活质量,具有良好的依从性和安全性。
Objective To observe the clinical effect of symbicort turbuhaler on bronchial asthma. Methods 50 asthmatic patients were treated with Symbicort turbuhaler, 2 times / day for 12 weeks. The relief of clinical symptoms, undesirable effects and the improvements ofpulmunary function were eval uated before and after inhalation therapy. Results The pulmonary function were improved. Conclusion Inhalation with Symbicort turbuhaler was an effect ire treatment for moderate to severe asthmatic patients,with good compliance and safety.
出处
《疾病监测与控制》
2009年第8期468-469,共2页
Journal of Diseases Monitor and Control
关键词
支气管哮喘
信必可都保
肺功能
Bronchial asthma
Symbicort turbuhaler
pulmonary function
